SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michael E. Østergaard, George Thomas, Erich Koller, Amber L. Southwell, Michael R. Hayden, Punit P. Seth, Biophysical and Biological Characterization of Hairpin and Molecular Beacon RNase H Active Antisense Oligonucleotides, ACS Chemical Biology, 2015, 10, 5, 1227

    CrossRef

  2. 2
    Tomoko Nishina, Junna Numata, Kazutaka Nishina, Kie Yoshida-Tanaka, Keiko Nitta, Wenying Piao, Rintaro Iwata, Shingo Ito, Hiroya Kuwahara, Takeshi Wada, Hidehiro Mizusawa, Takanori Yokota, Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol, Molecular Therapy—Nucleic Acids, 2015, 4, 1, e220

    CrossRef

  3. 3
    Richard S. Geary, Brenda F. Baker, Stanley T. Crooke, Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B, Clinical Pharmacokinetics, 2015, 54, 2, 133

    CrossRef

  4. 4
    Michael E. Østergaard, Jinghua Yu, Garth A. Kinberger, W. Brad Wan, Michael T. Migawa, Guillermo Vasquez, Karsten Schmidt, Hans J. Gaus, Heather M. Murray, Audrey Low, Eric E. Swayze, Thazha P. Prakash, Punit P. Seth, Efficient Synthesis and Biological Evaluation of 5′-GalNAc Conjugated Antisense Oligonucleotides, Bioconjugate Chemistry, 2015, 150610132419002

    CrossRef

  5. 5
    Juan F. Ascaso, Pedro Mata, Cristina Arbona, Fernando Civeira, Pedro Valdivielso, Luis Masana, Hipercolesterolemia familiar homocigota: adaptación a España del documento de posición del grupo de consenso sobre hipercolesterolemia familiar de la Sociedad Europea de Arteriosclerosis. Documento de Consenso de la Sociedad Española de Arteriosclerosis (SEA) y la Fundación Hipercolesterolemia Familiar (FHF), Clínica e Investigación en Arteriosclerosis, 2015, 27, 2, 80

    CrossRef

  6. 6
    Richard S. Geary, Daniel Norris, Rosie Yu, C. Frank Bennett, Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides, Advanced Drug Delivery Reviews, 2015,

    CrossRef

  7. 7
    Saadyah Averick, Ryan A. Mehl, Subha R. Das, Krzysztof Matyjaszewski, Well-defined biohybrids using reversible-deactivation radical polymerization procedures, Journal of Controlled Release, 2015, 205, 45

    CrossRef

  8. 8
    H.  ipova, T.  pringer, D. Rejman, O.  imak, M. Petrova, P. Novak,  arka Rosenbergova, O. Pav, R. Liboska, I. Barvik, J.  t panek, I. Rosenberg, J. Homola, 5'-O-Methylphosphonate nucleic acids--new modified DNAs that increase the Escherichia coli RNase H cleavage rate of hybrid duplexes, Nucleic Acids Research, 2014, 42, 8, 5378

    CrossRef

  9. 9
    Shuling Guo, Sheri L. Booten, Mariam Aghajan, Gene Hung, Chenguang Zhao, Keith Blomenkamp, Danielle Gattis, Andrew Watt, Susan M. Freier, Jeffery H. Teckman, Michael L. McCaleb, Brett P. Monia, Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin–related liver disease in mice, Journal of Clinical Investigation, 2014, 124, 1, 251

    CrossRef

  10. 10
    Daniela Castanotto, Cy A. Stein, Antisense oligonucleotides in cancer, Current Opinion in Oncology, 2014, 26, 6, 584

    CrossRef

  11. 11
    Shigeru Kawakami, Mitsuru Hashida, Glycosylation-mediated targeting of carriers, Journal of Controlled Release, 2014, 190, 542

    CrossRef

  12. 12
    M. Cuchel, E. Bruckert, H. N. Ginsberg, F. J. Raal, R. D. Santos, R. A. Hegele, J. A. Kuivenhoven, B. G. Nordestgaard, O. S. Descamps, E. Steinhagen-Thiessen, A. Tybjaerg-Hansen, G. F. Watts, M. Averna, C. Boileau, J. Boren, A. L. Catapano, J. C. Defesche, G. K. Hovingh, S. E. Humphries, P. T. Kovanen, L. Masana, P. Pajukanta, K. G. Parhofer, K. K. Ray, A. F. H. Stalenhoef, E. Stroes, M.-R. Taskinen, A. Wiegman, O. Wiklund, M. J. Chapman, M. Cuchel, E. Bruckert, M. J. Chapman, O. S. Descamps, H. N. Ginsberg, R. A. Hegele, J. A. Kuivenhoven, B. G. Nordestgaard, F. J. Raal, R. D. Santos, E. Steinhagen-Thiessen, A. Tybjaerg-Hansen, G. F. Watts, M. J. Chapman, H. N. Ginsberg, M. Averna, C. Boileau, J. Boren, A. L. Catapano, J. C. Defesche, G. K. Hovingh, S. E. Humphries, P. T. Kovanen, L. Masana, P. Pajukanta, K. G. Parhofer, K. K. Ray, A. F. H. Stalenhoef, E. Stroes, M.-R. Taskinen, A. Wiegman, O. Wiklund, Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society, European Heart Journal, 2014, 35, 32, 2146

    CrossRef

  13. 13
    Iddo Magen, Eran Hornstein, Oligonucleotide-based therapy for neurodegenerative diseases, Brain Research, 2014, 1584, 116

    CrossRef

  14. 14
    T. P. Prakash, M. J. Graham, J. Yu, R. Carty, A. Low, A. Chappell, K. Schmidt, C. Zhao, M. Aghajan, H. F. Murray, S. Riney, S. L. Booten, S. F. Murray, H. Gaus, J. Crosby, W. F. Lima, S. Guo, B. P. Monia, E. E. Swayze, P. P. Seth, Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice, Nucleic Acids Research, 2014, 42, 13, 8796

    CrossRef

  15. 15
    Mary P McGowan, Patrick M Moriarty, James M Backes, The effects of mipomersen, a second-generation antisense oligonucleotide, on atherogenic (apoB-containing) lipoproteins in the treatment of homozygous familial hypercholesterolemia, Clinical Lipidology, 2014, 9, 5, 487

    CrossRef

  16. 16
    M Ian Phillips, Andrew B Burns, The emergence of gene therapy for rare diseases, Expert Opinion on Orphan Drugs, 2014, 2, 11, 1197

    CrossRef

  17. 17
    Joanne Bronson, Amelia Black, Murali Dhar, Bruce Ellsworth, J. Robert Merritt, 2014,

    CrossRef